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Background: Cardiovascular Magnetic Resonance (CMR) myocardial perfusion imaging has the potential to evolve
into a method allowing full quantification of myocardial blood flow (MBF) in clinical routine. Multiple quantification
pathways have been proposed. However at present it remains unclear which algorithm is the most accurate. An
isolated perfused, magnetic resonance (MR) compatible pig heart model allows very accurate titration of MBF and
in combination with high-resolution assessment of fluorescently-labeled microspheres represents a near optimal
platform for validation. We sought to investigate which algorithm is most suited to quantify myocardial perfusion
by CMR at 1.5 and 3 Tesla using state of the art CMR perfusion techniques and quantification algorithms.
Methods: First-pass perfusion CMR was performed in an MR compatible blood perfused pig heart model. We
acquired perfusion images at physiological flow (“rest”), reduced flow (“ischaemia”) and during adenosine-induced
hyperaemia (“hyperaemia”) as well as during coronary occlusion. Perfusion CMR was performed at 1.5 Tesla (n = 4
animals) and at 3 Tesla (n = 4 animals). Fluorescently-labeled microspheres and externally controlled coronary blood
flow served as reference standards for comparison of different quantification strategies, namely Fermi function
deconvolution (Fermi), autoregressive moving average modelling (ARMA), exponential basis deconvolution
(Exponential) and B-spline basis deconvolution (B-spline).
Results: All CMR derived MBF estimates significantly correlated with microsphere results. The best correlation was
achieved with Fermi function deconvolution both at 1.5 Tesla (r = 0.93, p < 0.001) and at 3 Tesla (r = 0.9, p < 0.001). Fermi
correlated significantly better with the microspheres than all other methods at 3 Tesla (p < 0.002). B-spline performed
worse than Fermi and Exponential at 1.5 Tesla and showed the weakest correlation to microspheres (r = 0.74, p < 0.001).
All other comparisons were not significant. At 3 Tesla exponential deconvolution performed worst (r = 0.49, p < 0.001).
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Conclusions: CMR derived quantitative blood flow estimates correlate with true myocardial blood flow in a controlled
animal model. Amongst the different techniques, Fermi function deconvolution was the most accurate technique at
both field strengths. Perfusion CMR based on Fermi function deconvolution may therefore emerge as a useful clinical
tool providing accurate quantitative blood flow assessment.
Keywords: Cardiovascular magnetic resonance, Myocardial perfusion imaging, Quantification, Deconvolution,
Microspheres, Isolated heart perfusionBackground
Coronary artery disease (CAD) related myocardial in-
farction (MI) and heart failure constitute a leading cause
of death in the western world [1]. Myocardial ischaemia
represents the major pathophysiological substrate under-
lying these cardiovascular diseases and is known to be
the most important predictor of negative outcome after
revascularization in CAD [2]. Myocardial perfusion im-
aging can accurately determine myocardial ischaemia
and therefore detect the physiological significance of a
coronary artery narrowing which is not possible with lu-
minal angiography [3,4]. Myocardial perfusion imaging
with cardiovascular magnetic resonance (CMR) com-
pares favourably to other non-invasive techniques [5-9]
and is increasingly used for patient management and
clinical decision-making [10-12]. Perfusion CMR has
been validated against invasive hemodynamic measure-
ments such as coronary flow reserve (CFR) and frac-
tional flow reserve (FFR) [7,13-19]. The feasibility of full
quantification of myocardial blood flow (MBF) with per-
fusion CMR has been demonstrated [20-23] and has
been compared to positron emission computed tomog-
raphy (PET) based quantification [24]. Even though the
diagnostic accuracy for detection of significant CAD is
similar between quantitative PET and CMR the perfu-
sion estimates based on different mathematical models
vary between modalities [24]. Therefore, before perfu-
sion CMR quantification can become a clinically useful
diagnostic test for non-invasive assessment of MBF
[21], a number of important considerations still have
to be addressed: 1) full quantification of myocardial
perfusion is estimated from signal intensity (SI) time curves
and the relationship between arterial input function (AIF)
and myocardial response curves. Both SI time curves de-
pend on heart rate, cardiac output, ejection fraction, and
coronary anatomy and may not necessarily be the same for
a given sequence or field strength. 2) There are several
mathematical algorithms available for perfusion quantifica-
tion based on CMR derived SI-time curves such as Fermi
function deconvolution (Fermi), autoregressive moving
average modelling (ARMA), deconvolution using an expo-
nential basis (Exponential) and deconvolution using a B-
spline basis (B-spline). At present it is unknown which
mathematical algorithmis most accurate.We have recently introduced a novel MR compatible
explanted pig heart model that allows accurate control
of regional blood flow and therefore represents an ideal
vehicle for quantitative perfusion validation [25,26]. It is
also free of many of the influences mentioned above
which make quantification strategies difficult in living
animals or patients. Furthermore, CMR results of the
explanted pig heart model, which has precisely con-
trolled blood flow rates can be verified with the state of
the art imaging cryomicrotome technique [27]. This
technique provides an unprecedented reference-standard
for local tissue perfusion [28], via administration of dif-
ferently coloured fluorescently-labelled microspheres
into the bloodstream, which are quantified ex vivo from
high-resolution 3D reconstructions of the organ [29].
The aim of the current study was to investigate which
perfusion algorithm is most suited for quantitative ana-
lysis of perfusion CMR using this unique imaging set-up.
Methods
Experimental design of the study
All animal experiments were conducted after approval
by the U.K. Home Office in accordance with the U.K.
Animals (Scientific Procedures) Act of 1986 and in com-
pliance with the World Medical Association Declaration
of Helsinki regarding ethical conduct of research involv-
ing animals. Eight healthy Large White Cross Landrace
pigs weighing between 41 and 54 kg were included in
this study (Harlan Laboratories, UK). Hearts were
harvested as previously described [25,26]. Sedation was
performed with ketamine (10 mg/kg i.m.) and xylazine
(0.3 mg/kg i.m.) in combination with alphaxolone for
general intravenous anaesthesia (1.5 mg/kg i.v.). Heparin
was administered (5,000 IU) and exsanguination started
through the superior vena cava. A schematic drawing of
the set-up is provided elsewhere [25]. The hearts were
removed after transection of the great heart vessels and
intra-coronary infusion of cold (4°C) cardioplegic solu-
tion (Martindale Pharmaceuticals, Romford, Essex, UK)
was performed. Back in the MR-suite, catheters were
inserted into the coronary arteries for reperfusion. The
perfusion circuit was then connected to the catheters to
allow continuous blood perfusion of the coronary arter-
ies. A 3-way stopcock was used at the arterial side of the
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and adenosine. The stopcock was placed far away from
the heart to allow sufficient mixing of injected sub-
stances with the perfusing blood. Special attention was
drawn to precisely tape the arterial inflow tubing to the
outer wall of the heart chamber to allow a perpendicular
cut through the tubing within each perfusion slice acqui-
sition to derive the AIF [25]. To create left ventricular
(LV) preload a pressure balloon was inserted through
the aortic valve into the left ventricle and inflated to a
systolic pressure of 50 mmHg. After the hearts were
cannulated, pressure controlled perfusion of the coron-
ary arteries was started at around 50 mmHg. Arterial
perfusion pressure was measured using manometers
connected to the arterial inflow tubing. Over approxi-
mately 5 minutes pressure was slowly increased to a
constant perfusion mode of 0.8 mL/min/g. In the event
of ventricular fibrillation, electrical defibrillation was
performed. After preparation stability was achieved the
left anterior descending (LAD) coronary artery was oc-
cluded. The specific set-up of the explanted pig heart
model and the fact that there are virtually no collaterals
present in Large White Cross Landrace pigs allowed
creation of a territory with a perfusion defect and a
normally perfused remote territory and thus a variety
of different flow values for perfusion validation within
each animal. CMR imaging was started and perfusion-
CMR was performed (in randomized order) at rest,
with 50% flow reduction and during pharmacological
vasodilation with adenosine (Figure 1). During adeno-
sine infusion, the perfusion pressure dropped due to
the induced vasodilation. To achieve hyperaemia theFigure 1 Time-course of the CMR examination. After preparation stabi
rest perfusion images. This process was repeated with a 50% flow reduc
coronary perfusion pressure controlled increase in MBF. Microspheres w
for each perfusion scan. Please note that the order of the changes made to theflow was altered to restore the same coronary perfu-
sion pressure as during the resting state.
Cardiovascular magnetic resonance
The animal studies were performed on 1.5 Tesla (Achieva
CV, Philips, Best, The Netherlands), (n = 4) and 3 Tesla
(Achieva TX, Philips, Best, The Netherlands), (n = 4) clinical
MR scanners. For signal reception, a clinical interventional
L-flex receiver coil array was tightly positioned around the
heart chamber, which was then placed in the isocenter of
the magnet. Perfusion CMR data were acquired in short
axis orientation of the LV following a recognized standard
model [30].
Image parameters at 1.5 Tesla were as follows: CMR-
perfusion imaging was performed with a 5 fold k-t broad
linear speed up technique (BLAST) accelerated balanced
turbo gradient echo pulse sequence with 11 training pro-
files yielding a typical spatial resolution of 1.9×2×10
mm. TE/TR was 1.35/2.71; 50° flip angle; 90° prepulse
and 100 ms prepulse delay.
At 3 Tesla we used a saturation recovery gradient echo
pulse sequence accelerated with k–t BLAST (k-t factor 5
and 11 training profiles) with a repetition time of
2.7 ms, echo time of 0.9 ms, flip angle 20°, spatial reso-
lution at 1.3 × 1.3 × 8 mm.
Perfusion-CMR was performed using a dual bolus
scheme with 5 mL of dilute (0.007 mmol/mL) and 5 ml
of neat (0.07 mmol/mL) gadobutrol bolus injections
(Gadovist, Bayer Healthcare, Leverkusen, Germany) [31].
Perfusion images were acquired in three myocardial slices
according to the 16 segment model of the American Heart
Association (AHA) [30]. Post-processing of the perfusionlity was achieved, CMR imaging was started with the acquisition of
tion and during pharmacological vasodilation with adenosine with
ere injected after each gadolinium injection with a different colour
flow and the respective colour of injected microspheres were randomized.
Schuster et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:82 Page 4 of 13
http://jcmr-online.com/content/16/1/82images included the manual delineation of endocardial and
epicardial contours as well as selecting a region of interest
within the arterial inflow tubing to determine the AIF and
was performed with a dedicated software prototype (Philips
Healthcare, Best, The Netherlands) [25,32].
Quantitative analysis of perfusion CMR
The LV was divided into standard segments [30]. The
SI-time curves of the perfusion CMR images were incor-
porated into MATLAB (Natick, MA, USA) and different
algorithms for quantification were applied.
These quantification methods which are based on the
central volume principle [33] deconvolve the tissue sig-
nal during the first pass of a bolus of contrast agent with
the arterial input function normally sampled from the
LV or the arterial inflow tubing under the experimental
conditions of the current study.
According to the central volume principle the concen-
tration of the contrast agent in the tissue region Ctiss(t)
is related to the concentration of the contrast agent in
the arterial input region Caif(t) via the following convo-
lution equation:
Ctiss tð Þ ¼ Caif tð Þ ⊗ h tð Þ
where h(t) is the unknown tissue impulse response.
The above equation needs to be deconvolved to esti-
mate h(t) and therefore estimate the myocardial blood
flow (MBF) according to h(t = 0).
Deconvolution methods used in this work are Fermi
function deconvolution, (ARMA), Exponential basis de-
convolution and B-spline basis deconvolution [21,34].
These deconvolution algorithms consist of modelling
parameters and variables. The degree of splines, the
number of splines and the position of the break points
(control points) are the varying parameters in the B-
spline function. Similarly to B-spline, the total number
of exponential functions and the decay rates of the expo-
nential functions (or in other words the placement of
time scales and their distribution) are the modelling
parameters for exponential basis deconvolution. With
ARMA, no mathematical model is used for the representa-
tion of the tissue impulse response. The auto-regressive
and moving average order (Q and L respectively) are the
only factors, which have influence on the model’s accuracy.
The varying parameter in Fermi is a predefined parameter,
which is equal to the delay time between the arrival of
contrast agent at the site of the AIF, usually the LV (or the
inflow tubing in the current study) and the arrival in the
myocardium. This parameter which is called tOnset de-
pends on the placement of the individual region of interest
for measuring the AIF and the tissue response [35].
It is important to note that tOnset can affect the out-
come of all four deconvolution algorithms. Thereforethis parameter has to be taken into special consideration
when any of these methods is being used. Consequently
in this study, only the intensity values after arrival of the
contrast agent in the inflow tubing and myocardial tissue
have been used for quantification. Effects of variation of
these parameters on the outcome of deconvolution have
been previously demonstrated by our group [36].
The different algorithms and their sensitivity to
changes in the underlying modelling parameters are
highly affected by the quality of the data. Any perturb-
ation can affect the accuracy of the results and intro-
duce possible variation in the output of the process. In
order to render the deconvolution process more stable,
reduce the computational burden and obtain the most
accurate results we used 10 time scales for exponential
basis deconvolution, fourth-degree B-spline polynomial
with 15 equally spaced break points [36,37] and ARMA
(Q = 1,L = 2) for the representation of impulse response
[36]. Prior to deconvolution analysis, baseline correc-
tion, spatial and temporal filtering and homogeneity
correction was performed on the extracted SI curves.
Quantitative microsphere analysis using an imaging
cryomicrotome
Microspheres used were 15 μm in size and fluorescently
labelled with either of the following colours: green, yel-
low, red, carmine or scarlet (FluoSpheres®, Molecular
Probes Inc, Eugene, Oregon, USA). Before injection mi-
crospheres were sonicated and approximately 100,000
microspheres were diluted with whole blood to a total
volume of 2 ml. Immediately after the gadolinium injec-
tion microspheres were injected into the circulation over
a period of two minutes (1 ml/min injection speed) at
the same site used for gadolinium injection. Up to 3
different colours of microspheres were used during the
experiments. Quantitative analysis of the microtome
images was performed in the same standard segments
used for perfusion quantification according to previously
described methods [29]. In brief, the cryomicrotome
images with their superior spatial resolution depending
on slice thickness (range between hearts 59–100 μm)
and pixel density of the digital camera (4000 × 4000 pixel
Apogee Alta U-16 digital camera, USA; equipped with a
variable 70–180 mm focus lens, Nikon, The Netherlands)
effectively provided a point cloud of microspheres. To as-
sess microsphere deposition, this point cloud was aligned
with the heart geometry in the CMR images via image
registration - a process of anatomical landmark-based rigid
registration, followed by manual fine-tuning alignment of
anatomical features. Microsphere flow was quantified as a
function of segment volume, arterial flow rate, and
microsphere count fraction [29]. Accurate rigid registra-
tion was achieved by using a combination of anatomical
landmark-based rigid registration (i.e., identifying the
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fine manual rigid transformation adjustments using
the 3D visualisation software CMGUI (OpenCMISS
Continuum Mechanics, Imaging, Signal processing and
System identification; http://www.cmiss.org/cmgui).
This allowed exact alignment of the upper and lower
right ventricular (RV) insertion points in both images
and thus precise overlay of the CMR and microsphere
images (Figure 2). Each AHA segment in the MR
perfusion images (with known slice thickness) then
defined a volume within which spatially co-registered
microspheres were counted.Figure 2 Example illustrating the comparison of segmental perfusion b
a perfusion study at 3 Tesla after occlusion of the LAD is shown at the u
microsphere distribution after transfer of the cryomicrotome images in t
2D representation of the overlaid 3D perfusion and microsphere volume
CMR slices. There was good agreement between CMR and microsphere
microspheres. Segmental microsphere quantification reveals the perfusi
right corner). In the middle row segmentation of the perfusion image is
during first pass of gadolinium (middle). Using the SI-time curves with d
results [mL/min/g] depending on the algorithm used (lower row). In thi






where Ns is the number of microspheres counted in a
segment, Nt is the total number of microspheres
injected, Ft is the total arterial input flow rate in mL/
min, and Ms is the mass of a segment in grams. Segment
mass was derived from segment volume, which was cal-
culated from a fine 3D binarised left ventricular mesh.y CMR and microsphere techniques at rest. A single time frame of
pper left. The middle image (top row) shows the overlay with the
he same coordinate space. Please note that this image provides a
s of interest as defined by the slice thickness of the perfusion
derived perfusion values without any clustering or clumping of the
on defect and the normal perfusion in remote myocardium (upper
displayed (left), as well as segmental signal intensity (SI) time curves
ifferent quantification algorithms delivers CMR based quantitative
s example Fermi function deconvolution shows the closest
Figure 3 Agreement of quantitative perfusion analysis using different algorithms with the reference-standard of microsphere derived antitative perfusion at 1.5 Tesla. The top row
shows the correlation of CMR derived quantitative perfusion analysis using different algorithms with the reference-standard of microsphere derive quantitative perfusion (Microspheres MBF). The
bottom row shows the agreement between CMR derived perfusion and Microspheres MBF using the Bland Altman analysis. There was good corr tion with minimal error between CMR derived


















Figure 4 Agreement of quantitative perfusion analysis using different algorithms with the reference-standard of microsphere derived antitative perfusion at 3 Tesla. The top row
shows the correlation of quantitative perfusion analysis using different algorithms with the reference-standard of microsphere derived quantitativ erfusion (Microspheres MBF). The bottom row
shows the agreement between CMR derived perfusion and Microspheres MBF using the Bland Altman analysis. There was excellent correlation w minimal error between CMR derived



















Table 1 The table shows the correlation strength of the
individual algorithms with the reference-standard of
microspheres
1.5 Tesla 3 Tesla p-value
Algorithm r r
Fermi 0.93 0.9 <0.001
ARMA 0.88 0.59 <0.001
Exponential 0.92 0.49 <0.001
B-spline 0.74 0.64 <0.001
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same standard segments used for quantitative perfu-
sion CMR analysis, the LV centroid and anterior RV
insertion point were identified in each perfusion slice,
with circumferential segments then defined every 60
degrees around the centroid allowing very accurate
alignment of the respective perfusion and cryomicro-
tome segments (Figure 2).Statistics
Data analysis was performed with IBM SPSS statistics for
Mac 20.0.0 (SPSS Inc., Chicago, Illinois, USA). Continuous
data are expressed as the mean ± standard deviation (SD).
To compare quantitative perfusion measurements of the
different algorithms with CMR and microspheres we used
linear regression analysis and the method proposed by
Bland and Altman [38]. The Fisher z transformation was
used to compare the correlation strength of the individual
algorithms with the microsphere reference-standard. To
correct for multiple comparisons a Bonferroni adjustment
for post hoc analysis was performed.
The paired sample t-test was used to assess the mean
differences between perfusion measurements based on
CMR and with microspheres. Intra-observer variability
of perfusion CMR analysis was assessed using the coeffi-
cient of variation (CV) defined as the ratio of the SD to
the mean of the differences between the measurements.
A p-value of <0.05 was considered statistically signifi-
cant. P-values of less than 0.008 remained significant
after Bonferroni correction for multiple comparisons.Table 2 Comparison of the correlation coefficients of the indi
1.5 Tesla
Algorithm Fermi ARMA Exponential B-splin
Fermi p = 1 p = 0.06 p = 0.64 p = 0.0
ARMA p = 0.06 p = 1 p = 0.16 p = 0.0
Exponential p = 0.64 0.16 p = 1 p = 0.0
B-spline p = 0.001 0.04 p = 0.001 p = 1
The table shows the results of the comparison of the correlation coefficients of the
at both field strengths. In comparison with the other methods it performed signific
spline deconvolution but not than ARMA and exponential deconvolution. The compariso
reference-standard was based on Fisher z transformation. P values of less than 0.008 remResults
All the explanted hearts recovered electrical function
upon reperfusion. In case of reperfusion arrhythmias,
defibrillation was performed to achieve sinus rhythm.
Hearts were shocked for 3 ± 2 times on average. All
hearts remained reasonably stable throughout the perfu-
sion experiments. Heart Rate was 71 ± 15. The heart
weight was 272 ± 19 g. The external roller pump blood
flow was set to 238 ± 46 mL/min. Further measurements
were taken during reduced flow at 118 ± 20 mL/min and
during adenosine induced hyperemia with 392 ± 47 mL/
min. These flow rates constituted an overall LV perfu-
sion of 0.89 ± 0.18, 0.45 ± 0.1 and 1.47 ± 0.16 mL/min/g
LV, respectively. On a segmental level, perfusion esti-
mates derived from the different techniques based on
CMR SI-time curves were compared to those obtained
with microspheres. Figure 3 shows the relation between
segmental microsphere and CMR derived perfusion for
1.5 Tesla and Figure 4 for 3 Tesla.
All CMR derived MBF estimates correlated signifi-
cantly with those obtained by microspheres (Table 1).
The best correlation was achieved with Fermi function
deconvolution both at 1.5 Tesla (r = 0.93, p < 0.001) and
at 3 Tesla (r = 0.9, p < 0.001, Table 1).
Fermi function deconvolution correlated significantly
better with the microspheres as compared to all other
methods at 3 Tesla (p < 0.002, Table 2). Whilst it was
superior to B-spline at 1.5 Tesla (p = 0.001) there was
no difference with exponential deconvolution and
ARMA at 1.5 Tesla in terms of correlation strength
(p > 0.05, Table 2).
The Bland Altman analysis and 95% confidence inter-
vals of the difference showed excellent results for Fermi
with minimal overestimation of perfusion at 3 Tesla
(mean difference −0.01 ± 0.4 mL/min/g at 1.5 Tesla
and 0.07 ± 0.31 mL/min/g at 3 Tesla; see Table 3).
ARMA showed minimal underestimation of perfusion
at 3 Tesla (mean difference −0.05 ± 0.74 mL/min/g)
and moderate underestimation at 1.5 Tesla (mean dif-
ference −0.18 ± 0.59 mL/min/g). Exponential deconvo-
lution showed excellent results at 1.5 Tesla (mean
difference 0.06 ± 0.43 mL/min/g), however moderatevidual algorithms
3 Tesla
e Fermi ARMA Exponential B-spline
01 p = 1 p < 0.001 p < 0.001 p = 0.001
4 p < 0.001 p = 1 p = 0.36 p = 0.6
01 p < 0.001 p = 0.36 p = 1 p = 0.15
p = 0.001 p = 0.6 p = 0.15 p = 1
individual algorithms. Fermi function deconvolution had the strongest r-value
antly better at 3 Tesla. At 1.5 Tesla it performed significantly better than B-
n of the correlation strength of the individual algorithms with the microsphere
ained significant after Bonferroni correction for multiple comparisons.
Table 3 Mean perfusion values based on microspheres and CMR for both field strengths
Field strength Modality Mean [mL/min/g] Mean difference and CI (95%) of the difference p-value
1.5 Tesla Microspheres 1.17 ± 1.05
Fermi 1.15 ± 0.96 −0.01 ± 0.4 (−0.1-0.07) 0.74
ARMA 0.99 ± 0.62 −0.18 ± 0.59 (−0.3-(−0.06)) 0.04
Exponential 1.22 ± 0.83 0.06 ± 0.43 (−0.03-0.14) 0.22
B-spline 1.39 ± 1.17 0.23 ± 0.81 (0.06-0.39) 0.009
3 Tesla Microspheres 0.9 ± 0.72
Fermi 0.97 ± 0.66 0.07 ± 0.31 (0.002-0.14) 0.43
ARMA 0.85 ± 0.88 −0.05 ± 0.74 (−0.21-0.1) 0.5
Exponential 1.21 ± 0.74 0.3 ± 0.74 (0.14-0.46) <0.001
B-spline 1.34 ± 0.86 0.43 ± 0.68 (0.29-0.58) <0.001
Data is presented as mean ± standard deviation (SD) along with p-values indicating statistical significance based on the paired t-test. (CI)- Confidence Intervals;
(CMR)-cardiovascular magnetic resonance.
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ence 0.3 ± 0.74 mL/min/g). B-spline deconvolution
showed moderate overestimation of perfusion at both
field strengths (mean difference 0.23 ± 0.81 mL/min/g
at 1.5 Tesla and 0.43 ± 0.68 mL/min/g at 3 Tesla;
Figures 3 and 4, Table 3).
There was a trend towards more pronounced error
(i.e. underestimation or overestimation of perfusion) at
higher flow values (Table 4). Whilst Fermi showed the
least error amongst algorithms at high flow values the
error was most pronounced for ARMA deconvolution at
1.5 Tesla.
Intra-observer variability differed between algorithms.
Whilst B-spline showed minimal intra-observer variabil-
ity at both field strengths, the intra-observer variability
of Fermi deconvolution was minimal at 1.5 Tesla and
moderate to good at 3 Tesla. Exponential deconvolution
showed little intra-observer variability at both field
strengths whereas ARMA showed some variability at
both scanners (Table 5).Table 4 Mean perfusion values based on microspheres and C
values ≥ 2
Field strength Modality Mean [ml/min/g]
1.5 Tesla Microspheres 3.36 ± 1.11
Fermi 3.16 ± 1
ARMA 2.2 ± 0.5
Exponential 2.93 ± 0.61
B-spline 3.59 ± 1.5
3 Tesla Microspheres 2.57 ± 0.46
Fermi 2.51 ± 0.57
ARMA 3.03 ± 1
Exponential 2.4 ± 0.88
B-spline 3.34 ± 0.94
Data is presented as mean ± standard deviation (SD) along with p-values indicating
(CMR)- cardiovascular magnetic resonance.Discussion
The current study yielded several important findings.
Firstly, we demonstrated that Fermi function deconvolu-
tion quantitative magnetic resonance perfusion analysis
accurately assesses true myocardial blood flow at 1.5 and
3 Tesla using state of the art MR perfusion acquisitions.
Secondly, amongst four widely used perfusion quantifi-
cation algorithms Fermi function reaches the best correl-
ation coefficient and least error at both field strengths.
These findings are based on the utilisation of an
explanted heart model in a controlled environment
where myocardial blood flow is known and its distribu-
tion over time within the myocardium is quantified
with CMR and validated versus a microsphere depos-
ition method [29]. The availability of this reference-
standard allows the identification of underestimation
or overestimation of perfusion by a given CMR quanti-
fication algorithm. It is important to note that the
microsphere method we have employed arguably pro-
vides superior accuracy to previous methods, whereMR for both field strengths for microsphere perfusion
Mean difference and CI (95%) of the difference p-value
−0.2 ± 0.85 (−0.74-0.33) 0.42
−1.18 ± 1.02 (−1.84-(−0.53)) 0.02
−0.43 ± 0.81 (−0.94-0.08) 0.91
0.23 ± 1.84 (−0.94-1.4) 0.67
−0.07 ± 0.52 (−0.5-0.37) 0.72
0.46 ± 0.91 (−0.31-1.22) 0.2
−0.17 ± 0.68 (−0.74-0.4) 0.5
0.77 ± 0.78 (0.12-1.42) 0.03
statistical significance based on the paired t-test. (CI)- Confidence Intervals;
Table 5 Intra-observer variability of CMR quantitative
perfusion analysis as expressed by the coefficient of
variation (CV)
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corresponding to those used for flow quantification
from the perfusion CMR images [39-41]. In contrast to
this, the current method provides anatomical align-
ment of heart geometry from two imaging modalities
for the comparison of microspheres with perfusion
CMR. The current work shows that CMR derived quan-
titative perfusion imaging assessed with either Fermi,
ARMA, Exponential or B-spline deconvolution corre-
lates with fluorescently-labelled microspheres both at
1.5 and 3 Tesla. There is however a difference in the
performance of these algorithms. Whilst Fermi per-
forms best at both field strengths, B-spline shows the
biggest error at both field strengths. In the current work
Fermi function deconvolution is statistically signifi-
cantly superior to all other algorithms at 3 Tesla. At 1.5
Tesla, although Fermi function reaches the highest cor-
relation coefficient of all algorithms, it does not reach
statistically significant superiority over ARMA and ex-
ponential deconvolution. Fermi, ARMA and exponential
deconvolution have been shown to be less sensitive to
noise as compared to B-spline in an ex-vivo, synthetic
perfusion phantom [34]. In this phantom the perfusion
is known in the whole myocardial compartment [42]
and amongst the aforementioned algorithms Fermi
showed the least variability of error under very well
controlled experimental conditions [34]. It is interesting
to speculate whether the slightly lower perfusion values
measured with microspheres or the slightly higher ob-
server variability had an impact on the worse perform-
ance of ARMA, Exponential and B-spline deconvolution
at 3 Tesla. Notwithstanding these considerations the
fact that the performance of all algorithms at both field
strengths slightly decreased at higher perfusion values
and Fermi showed excellent performance at both field
strengths, which is in line with previous investigations
showing excellent correlations of Fermi with micro-
spheres both at 1.5 and 3 Tesla [39], would argue
against this theory. In line with this evidence the results
of the current paper add further weight to the value of
Fermi, which has also been shown to correlate with FFR
with excellent accuracy for the detection of significant
CAD using a similar sequence as employed in the
present paper at 3 Tesla [18].Clinically it is important that quantification algorithms
have good performance at both field strengths. Higher
spatial resolution MR perfusion acquisitions were shown
to offer greater visual diagnostic accuracy at 1.5 Tesla
most likely due to the increased detection of more sub-
endocardial ischaemia [43]. The higher spatial resolution
present at 3 Tesla compared to 1.5 Tesla should allow
even better detection of subendocardial ischaemia and
the detection of the severity of the ischaemia in addition
to its pure present and extent. Hsu et al. demonstrated
that perfusion gradients between subendocardial and
subepicardial perfusion can be detected using low spatial
resolution techniques and pixel wise quantification strat-
egies in patients [40]. This technique has also been de-
veloped for 3 Tesla and interestingly, Fermi function
deconvolution also showed the best results in pixel-wise
analysis at 3 Tesla [34]. On the other hand, there is re-
cent evidence from our group that standard kt-balanced
turbo field echo (kt-BTFE) based perfusion CMR at 1.5
Tesla has a similar diagnostic accuracy for quantitative
myocardial perfusion reserve analysis as compared to the
clinical reference-standard of quantification PET in patients
with CAD [24]. This sequence has also been selected in a
major ongoing perfusion CMR clinical trial (MR-INFORM,
clinicaltrials.gov NCT01236807) [44]. Our study shows that
it may also allow accurate quantitative perfusion analysis.
Sub-studies of the MR-INFORM trial aiming to investigate
its diagnostic accuracy and prognostic implications will cer-
tainly be of interest.
The detected differences in quantitative perfusion as-
sessment using different algorithms are likely to be real
because some unknown variables, that occur in patient
or in living animal studies, affecting quantitative perfu-
sion assessment do not exist in the explanted pig heart
model used in this study. These include the known
intracoronary blood flow rates and the fact that the AIF
is directly taken from the tubing connecting to the cor-
onaries. Quantification in the explanted heart is less
susceptible to external influences such as heart rate,
ejection fraction or cardiac output, factors that are all
known to heavily influence the shape of the AIF bolus
measured in the left ventricular cavity in patients. In
fact, in the current model we measure the AIF of the
bolus that directly and completely washes into the myo-
cardium. The current model may therefore be useful as
a new reference standard for quantitative perfusion val-
idation using CMR especially given the fact that tech-
niques are very easily translatable to patients.
Given the mounting evidence of the use of quantitative
perfusion analysis to detect early and subtle changes for
various diseases, we believe that Fermi function deconvolu-
tion represents an accurate and robust technique that can
be recommended at 1.5 and 3 Tesla using current state of
the art perfusion sequences. Whether this approach or
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ology such as the gradientogram method [45] or pixel wise
assessment of perfusion are most accurate will need to be
clarified in future studies [34,40].Limitations
The fact that the explanted heart is less physiological
and free from external influences such as changes in
heart rate and cardiac output makes it an ideal validation
platform for quantitative perfusion. However, this model
may oversimplify in vivo imaging conditions, where the
AIF cannot be measured directly and which suffer
from artifacts due to breathing motion during stress.
Consequently, within in-vivo perfusion quantification
experimental settings both CMR and microsphere
blood flow quantification techniques still require as-
sumptions (e.g. adequate reference flow measurements
with microspheres and adequate AIF measurements with
CMR) and therefore neither CMR in the current version
nor microspheres may provide absolute fully quantitative
measurements. Furthermore, future work should study per-
fusion under fully working-heart conditions to achieve sce-
narios that even closer resemble in-vivo physiology to
investigate the influence of different filling or working states
of the heart on quantitative perfusion analysis.
The current paper describes validation of different quan-
tification algorithms based on AHA segments. Future stud-
ies will also need to determine transmural differences of
perfusion from subendocardium to subepicardium and to
define the diagnostic merits of such assessments at a reso-
lution beyond the AHA segmental classification.Conclusions
CMR derived quantitative blood flow estimates accur-
ately assess true myocardial blood flow in a controlled
animal model. There are inherent differences between
the quantification algorithms used at 1.5 Tesla and 3
Tesla. Fermi function deconvolution qualifies as the
most accurate at both field strengths and may represent
a technique that allows perfusion CMR quantification to
develop into a useful clinical tool.
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